The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
The ‘cytokine storm’: molecular mechanisms and therapeutic prospects
Open accessAbstract
Cytokine storm syndrome has generally been described as a collection of clinical manifestations resulting from an overactivated immune system. Cytokine storms (CSs) are associated with various pathologies, as observed in infectious diseases, certain acquired or inherited immunodeficiencies and autoinflammatory diseases, or following therapeutic interventions. Despite the role of CS in tissue damage and multiorgan failure, a systematic understanding of its underlying molecular mechanisms is lacking. Recent studies demonstrate a positive feedback loop between cytokine release and cell death pathways; certain cytokines, PAMPs, and DAMPs, can activate inflammatory cell death, leading to further cytokine secretion. Here, we discuss recent progress in innate immunity and inflammatory cell death, providing insights into the cellular and molecular mechanisms of CSs and therapeutics that might quell ensuing life-threatening effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
IL‐6 in inflammation, immunity, and disease
Tanaka, T., Narazaki, M., & Kishimoto, T. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016295 · Cited by 5,046
Nitric oxide synthases: regulation and function
Forstermann, U., & Sessa, W. C. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr304 · Cited by 4,409
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222
Interferon-γ: an overview of signals, mechanisms and functions
Schroder, K., Hertzog, P. J., Ravasi, T., & Hume, D. A. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0603252 · Cited by 4,120
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
Rutgeerts, P., Sandborn, W. J., Feagan, B. G., Reinisch, W., Olson, A., Johanns, J., Travers, S., Rachmilewitz, D., Hanauer, S. B., Lichtenstein, G. R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050516 · Cited by 3,902
Fajgenbaum, D. C., & June, C. H. (2020) · New England Journal of Medicine · doi:10.1056/nejmra2026131 · Cited by 3,196
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149
Targan, S. R., Hanauer, S. B., van Deventer, S. J. H., Mayer, L., Present, D. H., Braakman, T., DeWoody, K. L., Schaible, T. F., & Rutgeerts, P. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371502 · Cited by 3,135
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Hadjadj, J., Yatim, N., Barnabei, L., Corneau, A., Boussier, J., Smith, N., Péré, H., Charbit, B., Bondet, V., Chenevier-Gobeaux, C., et al. (2020) · Science · doi:10.1126/science.abc6027 · Cited by 2,984
Current concepts in the diagnosis and management of cytokine release syndrome.
Lee, D. W., Gardner, R., Porter, D. L., Louis, C. U., Ahmed, N., Jensen, M., Grupp, S. A., & Mackall, C. L. (2014) · Blood · doi:10.1182/blood-2014-05-552729 · Cited by 2,806 · cited 2×
“It is commonly thought that CSS in these patients occurs due to the activation of bystander cells, particularly myeloid cells, by CAR-T cells in the tumor environment [12].”
BackgroundMaini, R., St Clair, E. W., Breedveld, F., Furst, D., Kalden, J., Weisman, M., Smolen, J., Emery, P., Harriman, G., Feldmann, M., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)05246-0 · Cited by 2,345
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Liu, E., Marin, D., Banerjee, P., Macapinlac, H. A., Thompson, P., Basar, R., Nassif Kerbauy, L., Overman, B., Thall, P., Kaplan, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1910607 · Cited by 2,217
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063842 · Cited by 2,164 · cited 1×
“Another earlier example of a T cell-engaging immunotherapy is the superagonist anti-CD28 monoclonal antibody TGN1412, which directly activates CD4 effector memory T cells and which induced rapid CSS within minutes after infusion in six healthy volunteers [65].”
BackgroundLongitudinal analyses reveal immunological misfiring in severe COVID-19
Lucas, C., Wong, P., Klein, J., Castro, T. B. R., Silva, J., Sundaram, M., Ellingson, M. K., Mao, T., Oh, J. E., Israelow, B., et al. (2020) · Nature · doi:10.1038/s41586-020-2588-y · Cited by 2,074
Dinarello, C. A. (2000) · Chest · doi:10.1378/chest.118.2.503 · Cited by 2,045
Interleukin-6 receptor antagonists in critically ill patients with Covid-19.
The REMAP-CAP Investigators (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2100433 · Cited by 1,962
Into the Eye of the Cytokine Storm
Tisoncik, J. R., Korth, M. J., Simmons, C. P., Farrar, J., Martin, T. R., & Katze, M. G. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05015-11 · Cited by 1,940
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
Kalil, A. C., Patterson, T. F., Mehta, A. K., Tomashek, K. M., Wolfe, C. R., Ghazaryan, V., Marconi, V. C., Ruiz-Palacios, G. M., Hsieh, L., Kline, S., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2031994 · Cited by 1,835
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
Sandborn, W. J., Su, C., Sands, B. E., D’Haens, G. R., Vermeire, S., Schreiber, S., Danese, S., Feagan, B. G., Reinisch, W., Niezychowski, W., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1606910 · Cited by 1,770
Karki, R., Sharma, B. R., Tuladhar, S., Williams, E. P., Zalduondo, L., Samir, P., Zheng, M., Sundaram, B., Banoth, B., Malireddi, R. K. S., et al. (2021) · Cell · doi:10.1016/j.cell.2020.11.025 · Cited by 1,734
Self-citationMan, S. M., Karki, R., & Kanneganti, T. (2017) · Immunological Reviews · doi:10.1111/imr.12534 · Cited by 1,657
Self-citationFailure to Regulate TNF-Induced NF-κB and Cell Death Responses in A20-Deficient Mice
Lee, E. G., Boone, D. L., Chai, S., Libby, S. L., Chien, M., Lodolce, J. P., & Ma, A. (2000) · Science · doi:10.1126/science.289.5488.2350 · Cited by 1,409
Norelli, M., Camisa, B., Barbiera, G., Falcone, L., Purevdorj, A., Genua, M., Sanvito, F., Ponzoni, M., Doglioni, C., Cristofori, P., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0036-4 · Cited by 1,406
Smolen, J. S., Beaulieu, A., Rubbert-Roth, A., Ramos-Remus, C., Rovensky, J., Alecock, E., Woodworth, T., & Alten, R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60453-5 · Cited by 1,399
Trial of tocilizumab in giant-cell arteritis
Stone, J. H., Tuckwell, K., Dimonaco, S., Klearman, M., Aringer, M., Blockmans, D., Brouwer, E., Cid, M. C., Dasgupta, B., Rech, J., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1613849 · Cited by 1,386
Genetic mechanisms of critical illness in COVID-19
The GenOMICC Investigators, Pairo-Castineira, E., The ISARIC4C Investigators, Initiative, T. C.-1. H. G., 23andMe Investigators, BRACOVID Investigators, Gen-COVID Investigators, Clohisey, S., Klaric, L., Bretherick, A. D., et al. (2021) · Nature · doi:10.1038/s41586-020-03065-y · Cited by 1,365
Cytokine storm and sepsis disease pathogenesis
Chousterman, B. G., Swirski, F. K., & Weber, G. F. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0639-8 · Cited by 1,330
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
Salama, C., Han, J., Yau, L., Reiss, W. G., Kramer, B., Neidhart, J. D., Criner, G. J., Kaplan-Lewis, E., Baden, R., Pandit, L., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2030340 · Cited by 1,291
CAR T cell–induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade
Giavridis, T., van der Stegen, S. J. C., Eyquem, J., Hamieh, M., Piersigilli, A., & Sadelain, M. (2018) · Nature Medicine · doi:10.1038/s41591-018-0041-7 · Cited by 1,272 · cited 2×
“strongly correlated with CSS severity and mortality [63].”
BackgroundTopp, M. S., Gökbuget, N., Stein, A. S., Zugmaier, G., O'Brien, S., Bargou, R. C., Dombret, H., Fielding, A. K., Heffner, L., Larson, R. A., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71170-2 · Cited by 1,269
JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
Schwartz, D. M., Kanno, Y., Villarino, A., Ward, M., Gadina, M., & O'Shea, J. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.201 · Cited by 1,266
Gianfrancesco, M., Hyrich, K. L., Al-Adely, S., Carmona, L., Danila, M. I., Gossec, L., Izadi, Z., Jacobsohn, L., Katz, P., Lawson-Tovey, S., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217871 · Cited by 1,141
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
Rosas, I. O., Bräu, N., Waters, M., Go, R. C., Hunter, B. D., Bhagani, S., Skiest, D., Aziz, M. S., Cooper, N., Douglas, I. S., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2028700 · Cited by 1,125
Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis
Fritsch, M., Günther, S. D., Schwarzer, R., Albert, M.-C., Schorn, F., Werthenbach, J. P., Schiffmann, L. M., Stair, N., Stocks, H., Seeger, J. M., et al. (2019) · Nature · doi:10.1038/s41586-019-1770-6 · Cited by 1,110
RIP3 mediates the embryonic lethality of caspase-8-deficient mice
Kaiser, W. J., Upton, J. W., Long, A. B., Livingston-Rosanoff, D., Daley-Bauer, L. P., Hakem, R., Caspary, T., & Mocarski, E. S. (2011) · Nature · doi:10.1038/nature09857 · Cited by 1,057
Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
Fleischmann, R., Kremer, J., Cush, J., Schulze-Koops, H., Connell, C. A., Bradley, J. D., Gruben, D., Wallenstein, G. V., Zwillich, S. H., & Kanik, K. S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109071 · Cited by 1,024
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
Bresnihan, B., Alvaro-Gracia, J. M., Cobby, M., Doherty, M., Domljan, Z., Emery, P., Nuki, G., Pavelka, K., Rau, R., Rozman, B., et al. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199812)41:12<2196::aid-art15>3.0.co;2-2 · Cited by 981
Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome
Ménasché, G., Pastural, E., Feldmann, J., Certain, S., Ersoy, F., Dupuis, S., Wulffraat, N., Bianchi, D., Fischer, A., Le Deist, F., et al. (2000) · Nature Genetics · doi:10.1038/76024 · Cited by 962
Feldmann, J., Callebaut, I., Raposo, G., Certain, S., Bacq, D., Dumont, C., Lambert, N., Ouachée-Chardin, M., Chedeville, G., Tamary, H., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00855-9 · Cited by 943
Linear ubiquitination prevents inflammation and regulates immune signalling
Gerlach, B., Cordier, S. M., Schmukle, A. C., Emmerich, C. H., Rieser, E., Haas, T. L., Webb, A. I., Rickard, J. A., Anderton, H., Wong, W. W.-L., et al. (2011) · Nature · doi:10.1038/nature09816 · Cited by 940
Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition
Goldbach-Mansky, R., Dailey, N. J., Canna, S. W., Gelabert, A., Jones, J., Rubin, B. I., Kim, H. J., Brewer, C., Zalewski, C., Wiggs, E., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055137 · Cited by 930
López, A., Lorente, J. A., Steingrub, J., Bakker, J., McLuckie, A., Willatts, S., Brockway, M., Anzueto, A., Holzapfel, L., Breen, D., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000105581.01815.c6 · Cited by 921
Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus
Walker, M. J., Barnett, T. C., McArthur, J. D., Cole, J. N., Gillen, C. M., Henningham, A., Sriprakash, K. S., Sanderson-Smith, M. L., & Nizet, V. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00101-13 · Cited by 908
Targeting Interleukin-6 Signaling in Clinic
Kang, S., Tanaka, T., Narazaki, M., & Kishimoto, T. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.026 · Cited by 904
Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis
Günther, C., Martini, E., Wittkopf, N., Amann, K., Weigmann, B., Neumann, H., Waldner, M. J., Hedrick, S. M., Tenzer, S., Neurath, M. F., et al. (2011) · Nature · doi:10.1038/nature10400 · Cited by 884
Le, R. Q., Li, L., Yuan, W., Shord, S. S., Nie, L., Habtemariam, B. A., Przepiorka, D., Farrell, A. T., & Pazdur, R. (2018) · The Oncologist · doi:10.1634/theoncologist.2018-0028 · Cited by 873
Opal, S. M., Fisher, C. J., Dhainaut, J.-F. A., Vincent, J.-L., Brase, R., Lowry, S. F., Sadoff, J. C., Slotman, G. J., Levy, H., Balk, R. A., et al. (1997) · Critical Care Medicine · doi:10.1097/00003246-199707000-00010 · Cited by 865
Leisman, D. E., Ronner, L., Pinotti, R., Taylor, M. D., Sinha, P., Calfee, C. S., Hirayama, A. V., Mastroiani, F., Turtle, C. J., Harhay, M. O., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30404-5 · Cited by 855
Evidence of a Role of Tumor Necrosis Factor α in Refractory Asthma
Berry, M. A., Hargadon, B., Shelley, M., Parker, D., Shaw, D. E., Green, R. H., Bradding, P., Brightling, C. E., Wardlaw, A. J., & Pavord, I. D. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa050580 · Cited by 826
Lee, J. S., Park, S., Jeong, H. W., Ahn, J. Y., Choi, S. J., Lee, H., Choi, B., Nam, S. K., Sa, M., Kwon, J.-S., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abd1554 · Cited by 825
Kuriakose, T., Man, S. M., Subbarao Malireddi, R. K., Karki, R., Kesavardhana, S., Place, D. E., Neale, G., Vogel, P., & Kanneganti, T.-D. (2016) · Science Immunology · doi:10.1126/sciimmunol.aag2045 · Cited by 818
Self-citationApoptosis and caspases regulate death and inflammation in sepsis
Hotchkiss, R. S., & Nicholson, D. W. (2006) · Nature Reviews Immunology · doi:10.1038/nri1943 · Cited by 795
Picard, C., Bobby Gaspar, H., Al-Herz, W., Bousfiha, A., Casanova, J.-L., Chatila, T., Crow, Y. J., Cunningham-Rundles, C., Etzioni, A., Franco, J. L., et al. (2018) · Journal of Clinical Immunology · doi:10.1007/s10875-017-0464-9 · Cited by 795
Yokota, S., Imagawa, T., Mori, M., Miyamae, T., Aihara, Y., Takei, S., Iwata, N., Umebayashi, H., Murata, T., Miyoshi, M., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60454-7 · Cited by 789
Ravelli, A., Minoia, F., Davì, S., Horne, A., Bovis, F., Pistorio, A., Aricò, M., Avcin, T., Behrens, E. M., De Benedetti, F., et al. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39332 · Cited by 773
Thomas, P. G., Dash, P., Aldridge, J. R., Ellebedy, A. H., Reynolds, C., Funk, A. J., Martin, W. J., Lamkanfi, M., Webby, R. J., Boyd, K. L., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.02.006 · Cited by 746
Self-citationMalireddi, R. K. S., Kesavardhana, S., & Kanneganti, T.-D. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00406 · Cited by 741
Self-citationJordan, M. B., Hildeman, D., Kappler, J., & Marrack, P. (2004) · Blood · doi:10.1182/blood-2003-10-3413 · Cited by 712
Kanneganti, T.-D., Body-Malapel, M., Amer, A., Park, J.-H., Whitfield, J., Franchi, L., Taraporewala, Z. F., Miller, D., Patton, J. T., Inohara, N., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607594200 · Cited by 711
Self-citationPapp, K. A., Tyring, S., Lahfa, M., Prinz, J., Griffiths, C. E. M., Nakanishi, A. M., Zitnik, R., van de Kerkhof, P. C. M., & the Etanercept Psoriasis Study Group (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06688.x · Cited by 693
An interferon‐γ‐related cytokine storm in SARS patients
Huang, K., Su, I., Theron, M., Wu, Y., Lai, S., Liu, C., & Lei, H. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20255 · Cited by 679
Cytokine dysregulation and acute graft-versus-host disease
Antin, J., & Ferrara, J. (1992) · Blood · doi:10.1182/blood.v80.12.2964.2964 · Cited by 662
Winkler, U., Jensen, M., Manzke, O., Schulz, H., Diehl, V., & Engert, A. (1999) · Blood · doi:10.1182/blood.v94.7.2217.419k02_2217_2224 · Cited by 657
Interleukin-1–Receptor Antagonist in the Muckle–Wells Syndrome
Hawkins, P. N., Lachmann, H. J., & McDermott, M. F. (2003) · New England Journal of Medicine · doi:10.1056/nejm200306193482523 · Cited by 654
RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL
Lawlor, K. E., Khan, N., Mildenhall, A., Gerlic, M., Croker, B. A., D’Cruz, A. A., Hall, C., Kaur Spall, S., Anderton, H., Masters, S. L., et al. (2015) · Nature Communications · doi:10.1038/ncomms7282 · Cited by 649
Anakinra for severe forms of COVID-19: a cohort study
Huet, T., Beaussier, H., Voisin, O., Jouveshomme, S., Dauriat, G., Lazareth, I., Sacco, E., Naccache, J.-M., Bézie, Y., Laplanche, S., et al. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30164-8 · Cited by 643
Teachey, D. T., Rheingold, S. R., Maude, S. L., Zugmaier, G., Barrett, D. M., Seif, A. E., Nichols, K. E., Suppa, E. K., Kalos, M., Berg, R. A., et al. (2013) · Blood · doi:10.1182/blood-2013-02-485623 · Cited by 613
IRF7: activation, regulation, modification and function
Ning, S., Pagano, J. S., & Barber, G. N. (2011) · Genes & Immunity · doi:10.1038/gene.2011.21 · Cited by 601
FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation
Welz, P.-S., Wullaert, A., Vlantis, K., Kondylis, V., Fernández-Majada, V., Ermolaeva, M., Kirsch, P., Sterner-Kock, A., van Loo, G., & Pasparakis, M. (2011) · Nature · doi:10.1038/nature10273 · Cited by 594 · cited 5×
“However, FaddTnf mice still exhibit inflammation compared with wild-type mice, suggesting that TNF-independent mechanisms also contribute to FADD deficiency-induced pathology in mouse intestinal epithelial cells [115].”
BackgroundInfluentialRIPK1 Regulates RIPK3-MLKL-Driven Systemic Inflammation and Emergency Hematopoiesis
Rickard, J. A., O’Donnell, J. A., Evans, J. M., Lalaoui, N., Poh, A. R., Rogers, T., Vince, J. E., Lawlor, K. E., Ninnis, R. L., Anderton, H., et al. (2014) · Cell · doi:10.1016/j.cell.2014.04.019 · Cited by 593
Tularemia: History, Epidemiology, Pathogen Physiology, and Clinical Manifestations
SJÖSTEDT, A. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1409.009 · Cited by 593
Christgen, S., Zheng, M., Kesavardhana, S., Karki, R., Malireddi, R. K. S., Banoth, B., Place, D. E., Briard, B., Sharma, B. R., Tuladhar, S., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00237 · Cited by 588
Self-citationGasdermin E–mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome
Liu, Y., Fang, Y., Chen, X., Wang, Z., Liang, X., Zhang, T., Liu, M., Zhou, N., Lv, J., Tang, K., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.aax7969 · Cited by 566 · cited 2×
“Subsequent inflammatory cell death and tumor lysis induce aCS through the release of inflammatory cytokines [62].”
BackgroundRIPK1 Blocks Early Postnatal Lethality Mediated by Caspase-8 and RIPK3
Dillon, C. P., Weinlich, R., Rodriguez, D. A., Cripps, J. G., Quarato, G., Gurung, P., Verbist, K. C., Brewer, T. L., Llambi, F., Gong, Y.-N., et al. (2014) · Cell · doi:10.1016/j.cell.2014.04.018 · Cited by 562 · cited 2×
“The lethal phenotype caused by RIPK1 deficiency is rescued in mice by co-deletion of the proapoptotic CASP8 and the pronecroptotic RIPK3, but not by individual deletions of CASP8, RIPK3 or the downstream necroptosis effector MLKL, suggesting that there is redundancy between apoptosis and necroptosis in driving the CS…”
BackgroundSelf-citationzur Stadt, U. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi076 · Cited by 562
Gurung, P., Anand, P. K., Malireddi, R. K. S., Vande Walle, L., Van Opdenbosch, N., Dillon, C. P., Weinlich, R., Green, D. R., Lamkanfi, M., & Kanneganti, T.-D. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302839 · Cited by 558
Self-citationQuartier, P., Allantaz, F., Cimaz, R., Pillet, P., Messiaen, C., Bardin, C., Bossuyt, X., Boutten, A., Bienvenu, J., Duquesne, A., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.134254 · Cited by 558
Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock
Monneret, G., Lepape, A., Voirin, N., Bohé, J., Venet, F., Debard, A.-L., Thizy, H., Bienvenu, J., Gueyffier, F., & Vanhems, P. (2006) · Intensive Care Medicine · doi:10.1007/s00134-006-0204-8 · Cited by 545
Staphylococcal and Streptococcal Superantigen Exotoxins
Spaulding, A. R., Salgado-Pabón, W., Kohler, P. L., Horswill, A. R., Leung, D. Y. M., & Schlievert, P. M. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00104-12 · Cited by 540
Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis
Locatelli, F., Jordan, M. B., Allen, C., Cesaro, S., Rizzari, C., Rao, A., Degar, B., Garrington, T. P., Sevilla, J., Putti, M.-C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1911326 · Cited by 534
Caspase-6 Is a Key Regulator of Innate Immunity, Inflammasome Activation, and Host Defense
Zheng, M., Karki, R., Vogel, P., & Kanneganti, T.-D. (2020) · Cell · doi:10.1016/j.cell.2020.03.040 · Cited by 530
Self-citationCaspase inhibitors improve survival in sepsis: a critical role of the lymphocyte
Hotchkiss, R. S., Chang, K. C., Swanson, P. E., Tinsley, K. W., Hui, J. J., Klender, P., Xanthoudakis, S., Roy, S., Black, C., Grimm, E., et al. (2000) · Nature Immunology · doi:10.1038/82741 · Cited by 526
Molecular basis of group A streptococcal virulence
Bisno, A., Brito, M., & Collins, C. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00576-0 · Cited by 510
Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis
Vande Walle, L., Van Opdenbosch, N., Jacques, P., Fossoul, A., Verheugen, E., Vogel, P., Beyaert, R., Elewaut, D., Kanneganti, T.-D., van Loo, G., et al. (2014) · Nature · doi:10.1038/nature13322 · Cited by 506
Self-citationCanakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes
De Benedetti, F., Gattorno, M., Anton, J., Ben-Chetrit, E., Frenkel, J., Hoffman, H. M., Koné-Paut, I., Lachmann, H. J., Ozen, S., Simon, A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1706314 · Cited by 486
Z-nucleic-acid sensing triggers ZBP1-dependent necroptosis and inflammation
Jiao, H., Wachsmuth, L., Kumari, S., Schwarzer, R., Lin, J., Eren, R. O., Fisher, A., Lane, R., Young, G. R., Kassiotis, G., et al. (2020) · Nature · doi:10.1038/s41586-020-2129-8 · Cited by 486
The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology
Vereecke, L., Beyaert, R., & van Loo, G. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.05.007 · Cited by 482
Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target
Mifflin, L., Ofengeim, D., & Yuan, J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0071-y · Cited by 479
Boisson, B., Laplantine, E., Prando, C., Giliani, S., Israelsson, E., Xu, Z., Abhyankar, A., Israël, L., Trevejo-Nunez, G., Bogunovic, D., et al. (2012) · Nature Immunology · doi:10.1038/ni.2457 · Cited by 474
Musone, S. L., Taylor, K. E., Lu, T. T., Nititham, J., Ferreira, R. C., Ortmann, W., Shifrin, N., Petri, M. A., Ilyas Kamboh, M., Manzi, S., et al. (2008) · Nature Genetics · doi:10.1038/ng.202 · Cited by 470
Prevention of lymphocyte cell death in sepsis improves survival in mice
Hotchkiss, R. S., Tinsley, K. W., Swanson, P. E., Chang, K. C., Cobb, J. P., Buchman, T. G., Korsmeyer, S. J., & Karl, I. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14541 · Cited by 454
Manipulation of Host Cell Death Pathways during Microbial Infections
Lamkanfi, M., & Dixit, V. M. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.06.007 · Cited by 454
Le Goffic, R., Pothlichet, J., Vitour, D., Fujita, T., Meurs, E., Chignard, M., & Si-Tahar, M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3368 · Cited by 436
Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
Cantini, F., Niccoli, L., Matarrese, D., Nicastri, E., Stobbione, P., & Goletti, D. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.04.017 · Cited by 436
Time to Hit HIV, Early and Hard
Ho, D. D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508173330710 · Cited by 431
zur Stadt, U., Rohr, J., Seifert, W., Koch, F., Grieve, S., Pagel, J., Strauß, J., Kasper, B., Nürnberg, G., Becker, C., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.09.005 · Cited by 427
RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation
Lin, J., Kumari, S., Kim, C., Van, T.-M., Wachsmuth, L., Polykratis, A., & Pasparakis, M. (2016) · Nature · doi:10.1038/nature20558 · Cited by 421
Oxygen Radicals in Influenza-Induced Pathogenesis and Treatment with Pyran Polymer-Conjugated SOD
Oda, T., Akaike, T., Hamamoto, T., Suzuki, F., Hirano, T., & Maeda, H. (1989) · Science · doi:10.1126/science.2543070 · Cited by 418
Weiss, E. S., Girard-Guyonvarc’h, C., Holzinger, D., de Jesus, A. A., Tariq, Z., Picarsic, J., Schiffrin, E. J., Foell, D., Grom, A. A., Ammann, S., et al. (2018) · Blood · doi:10.1182/blood-2017-12-820852 · Cited by 395
RIPK1 inhibits ZBP1-driven necroptosis during development
Newton, K., Wickliffe, K. E., Maltzman, A., Dugger, D. L., Strasser, A., Pham, V. C., Lill, J. R., Roose-Girma, M., Warming, S., Solon, M., et al. (2016) · Nature · doi:10.1038/nature20559 · Cited by 390
Signaling events involved in anti-CD20-induced apoptosis of malignant human B cells
Shan, D., Ledbetter, J. A., & Press, O. W. (2000) · Cancer Immunology, Immunotherapy · doi:10.1007/s002620050016 · Cited by 385
Malireddi, R. K. S., Gurung, P., Kesavardhana, S., Samir, P., Burton, A., Mummareddy, H., Vogel, P., Pelletier, S., Burgula, S., & Kanneganti, T.-D. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20191644 · Cited by 384
Self-citationOverexpression of Bcl-2 in Transgenic Mice Decreases Apoptosis and Improves Survival in Sepsis
Hotchkiss, R. S., Swanson, P. E., Knudson, C. M., Chang, K. C., Cobb, J. P., Osborne, D. F., Zollner, K. M., Buchman, T. G., Korsmeyer, S. J., & Karl, I. E. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.4148 · Cited by 381
Activity of caspase-8 determines plasticity between cell death pathways
Newton, K., Wickliffe, K. E., Maltzman, A., Dugger, D. L., Reja, R., Zhang, Y., Roose-Girma, M., Modrusan, Z., Sagolla, M. S., Webster, J. D., et al. (2019) · Nature · doi:10.1038/s41586-019-1752-8 · Cited by 379
Accelerated Lymphocyte Death in Sepsis Occurs by both the Death Receptor and Mitochondrial Pathways
Hotchkiss, R. S., Osmon, S. B., Chang, K. C., Wagner, T. H., Coopersmith, C. M., & Karl, I. E. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.5110 · Cited by 343
Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease
Lalaoui, N., Boyden, S. E., Oda, H., Wood, G. M., Stone, D. L., Chau, D., Liu, L., Stoffels, M., Kratina, T., Lawlor, K. E., et al. (2020) · Nature · doi:10.1038/s41586-019-1828-5 · Cited by 333
Papp, K. A., Menter, M. A., Abe, M., Elewski, B., Feldman, S. R., Gottlieb, A. B., Langley, R., Luger, T., Thaci, D., Buonanno, M., et al. (2015) · British Journal of Dermatology · doi:10.1111/bjd.14018 · Cited by 327
Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome
Kotch, C., Barrett, D., & Teachey, D. T. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1629904 · Cited by 324
Webster, J. D., & Vucic, D. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00365 · Cited by 316
Dietary modulation of the microbiome affects autoinflammatory disease
Lukens, J. R., Gurung, P., Vogel, P., Johnson, G. R., Carter, R. A., McGoldrick, D. J., Bandi, S. R., Calabrese, C. R., Walle, L. V., Lamkanfi, M., et al. (2014) · Nature · doi:10.1038/nature13788 · Cited by 314 · cited 1×
“Specifically, whereas neutrophils and IL-1β are crucial for the initiation of the disease in Pstpip2 mice, joint inflammation and cytokine release are inhibited in Pstpip2Ripk3 Casp8Casp1/11 mice [33,121].”
BackgroundSelf-citationGut stem cell necroptosis by genome instability triggers bowel inflammation
Wang, R., Li, H., Wu, J., Cai, Z.-Y., Li, B., Ni, H., Qiu, X., Chen, H., Liu, W., Yang, Z.-H., et al. (2020) · Nature · doi:10.1038/s41586-020-2127-x · Cited by 314
Tumour-necrosis-factor antibody treatment in Crohn's disease
Derkx, B., Taminiau, J., Radema, S., Stronkhorst, A., Wortel, C., Tytgat, G., & van Deventer, S. (1993) · The Lancet · doi:10.1016/0140-6736(93)91375-v · Cited by 308
Jagasia, M., Perales, M.-A., Schroeder, M. A., Ali, H., Shah, N. N., Chen, Y.-B., Fazal, S., Dawkins, F. W., Arbushites, M. C., Tian, C., et al. (2020) · Blood · doi:10.1182/blood.2020004823 · Cited by 306
Eastwood, D., Findlay, L., Poole, S., Bird, C., Wadhwa, M., Moore, M., Burns, C., Thorpe, R., & Stebbings, R. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00922.x · Cited by 300 · cited 2×
“response to TGN1412 was deemed to be due to a lack of CD28 expression on CD4 effector memory T cells in macaques, preventing TGN1412 from activating these cells and inducing cytokine production [66].”
BackgroundEvidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha
Doherty, G. M., Lange, J. R., Langstein, H. N., Alexander, H. R., Buresh, C. M., & Norton, J. A. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.5.1666 · Cited by 300 · cited 2×
“Intraperitoneal injection of TNF and IFN-γ induces mortality in mice [23,74], mirroring themajor symptoms of CSS observed in patientswith COVID-19 [23].”
BackgroundBonnet, M. C., Preukschat, D., Welz, P.-S., van Loo, G., Ermolaeva, M. A., Bloch, W., Haase, I., & Pasparakis, M. (2011) · Immunity · doi:10.1016/j.immuni.2011.08.014 · Cited by 295
Boisson, B., Laplantine, E., Dobbs, K., Cobat, A., Tarantino, N., Hazen, M., Lidov, H. G. W., Hopkins, G., Du, L., Belkadi, A., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141130 · Cited by 295
Gabay, C., Fautrel, B., Rech, J., Spertini, F., Feist, E., Kötter, I., Hachulla, E., Morel, J., Schaeverbeke, T., Hamidou, M. A., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-212608 · Cited by 291
Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome
Mazodier, K. (2005) · Blood · doi:10.1182/blood-2005-05-1980 · Cited by 290
Mehta, P., Cron, R. Q., Hartwell, J., Manson, J. J., & Tattersall, R. S. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30096-5 · Cited by 285
Onizawa, M., Oshima, S., Schulze-Topphoff, U., Oses-Prieto, J. A., Lu, T., Tavares, R., Prodhomme, T., Duong, B., Whang, M. I., Advincula, R., et al. (2015) · Nature Immunology · doi:10.1038/ni.3172 · Cited by 284
Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology
Hussell, T., Pennycook, A., & Openshaw, P. J. M. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200109)31:9<2566::aid-immu2566>3.0.co;2-l · Cited by 283
Interferon regulatory factor 1 regulates PANoptosis to prevent colorectal cancer
Karki, R., Sharma, B. R., Lee, E., Banoth, B., Malireddi, R. K. S., Samir, P., Tuladhar, S., Mummareddy, H., Burton, A. R., Vogel, P., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.136720 · Cited by 282
Self-citationA dominant autoinflammatory disease caused by non-cleavable variants of RIPK1
Tao, P., Sun, J., Wu, Z., Wang, S., Wang, J., Li, W., Pan, H., Bai, R., Zhang, J., Wang, Y., et al. (2020) · Nature · doi:10.1038/s41586-019-1830-y · Cited by 276
Imashuku, S. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(02)00117-8 · Cited by 271
Mudd, P. A., Crawford, J. C., Turner, J. S., Souquette, A., Reynolds, D., Bender, D., Bosanquet, J. P., Anand, N. J., Striker, D. A., Martin, R. S., et al. (2020) · Science Advances · doi:10.1126/sciadv.abe3024 · Cited by 269
Corticosteroids as adjunctive therapy in the treatment of influenza
Rodrigo, C., Leonardi-Bee, J., Nguyen-Van-Tam, J., & Lim, W. S. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010406.pub2 · Cited by 264
Toxin-Induced Necroptosis Is a Major Mechanism of Staphylococcus aureus Lung Damage
Kitur, K., Parker, D., Nieto, P., Ahn, D. S., Cohen, T. S., Chung, S., Wachtel, S., Bueno, S., & Prince, A. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004820 · Cited by 263
TNFR1-dependent cell death drives inflammation in Sharpin-deficient mice
Rickard, J. A., Anderton, H., Etemadi, N., Nachbur, U., Darding, M., Peltzer, N., Lalaoui, N., Lawlor, K. E., Vanyai, H., Hall, C., et al. (2014) · eLife · doi:10.7554/elife.03464 · Cited by 262
A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis
Harrison, S. A., Goodman, Z., Jabbar, A., Vemulapalli, R., Younes, Z. H., Freilich, B., Sheikh, M. Y., Schattenberg, J. M., Kayali, Z., Zivony, A., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.11.024 · Cited by 260
Mahlaoui, N., Ouachée-Chardin, M., de Saint Basile, G., Neven, B., Picard, C., Blanche, S., & Fischer, A. (2007) · Pediatrics · doi:10.1542/peds.2006-3164 · Cited by 256
Macroscopic Postmortem Findings in 235 Surgical Intensive Care Patients with Sepsis
Torgersen, C., Moser, P., Luckner, G., Mayr, V., Jochberger, S., Hasibeder, W. R., & Dünser, M. W. (2009) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e318195e11d · Cited by 254
Spectrum of Perforin Gene Mutations in Familial Hemophagocytic Lymphohistiocytosis
Göransdotter Ericson, K., Fadeel, B., Nilsson-Ardnor, S., Söderhäll, C., Samuelsson, A., Janka, G., Schneider, M., Gürgey, A., Yalman, N., Révész, T., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/318796 · Cited by 251
Cytokine storm of graft-versus-host disease: a critical effector role for interleukin-1.
Ferrara, J. L., Abhyankar, S., & Gilliland, D. G. (1993) · PubMed · Cited by 249
TAK1 restricts spontaneous NLRP3 activation and cell death to control myeloid proliferation
Malireddi, R. K. S., Gurung, P., Mavuluri, J., Dasari, T. K., Klco, J. M., Chi, H., & Kanneganti, T.-D. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20171922 · Cited by 247
Self-citationCuchet-Lourenço, D., Eletto, D., Wu, C., Plagnol, V., Papapietro, O., Curtis, J., Ceron-Gutierrez, L., Bacon, C. M., Hackett, S., Alsaleem, B., et al. (2018) · Science · doi:10.1126/science.aar2641 · Cited by 243
Alvarez-Diaz, S., Dillon, C. P., Lalaoui, N., Tanzer, M. C., Rodriguez, D. A., Lin, A., Lebois, M., Hakem, R., Josefsson, E. C., O’Reilly, L. A., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.07.016 · Cited by 242
RIPK1 Distinctly Regulates Yersinia-Induced Inflammatory Cell Death, PANoptosis
Malireddi, R. K. S., Kesavardhana, S., Karki, R., Kancharana, B., Burton, A. R., & Kanneganti, T.-D. (2020) · ImmunoHorizons · doi:10.4049/immunohorizons.2000097 · Cited by 224
Self-citationPierdomenico, M., Negroni, A., Stronati, L., Vitali, R., Prete, E., Bertin, J., Gough, P. J., Aloi, M., & Cucchiara, S. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.403 · Cited by 216
Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines
Lee, S., Channappanavar, R., & Kanneganti, T.-D. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.10.005 · Cited by 209
Self-citationLUBAC is essential for embryogenesis by preventing cell death and enabling haematopoiesis
Peltzer, N., Darding, M., Montinaro, A., Draber, P., Draberova, H., Kupka, S., Rieser, E., Fisher, A., Hutchinson, C., Taraborrelli, L., et al. (2018) · Nature · doi:10.1038/s41586-018-0064-8 · Cited by 206
Strati, P., Ahmed, S., Kebriaei, P., Nastoupil, L. J., Claussen, C. M., Watson, G., Horowitz, S. B., Brown, A. R. T., Do, B., Rodriguez, M. A., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020002328 · Cited by 201
Schmid, J. P., Ho, C., Chrétien, F., Lefebvre, J. M., Pivert, G., Kosco‐Vilbois, M., Ferlin, W., Geissmann, F., Fischer, A., & de Saint Basile, G. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900009 · Cited by 196
Bode, S. F., Ammann, S., Al-Herz, W., Bataneant, M., Dvorak, C. C., Gehring, S., Gennery, A., Gilmour, K. C., Gonzalez-Granado, L. I., Gross-Wieltsch, U., et al. (2015) · Haematologica · doi:10.3324/haematol.2014.121608 · Cited by 196
Cruz, M. P. (2018) · PubMed · Cited by 188
Kesavardhana, S., Malireddi, R. K. S., Burton, A. R., Porter, S. N., Vogel, P., Pruett-Miller, S. M., & Kanneganti, T.-D. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013752 · Cited by 181
Self-citationPearson, J. S., Giogha, C., Mühlen, S., Nachbur, U., Pham, C. L. L., Zhang, Y., Hildebrand, J. M., Oates, C. V., Lung, T. W. F., Ingle, D., et al. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.258 · Cited by 179
GSDMD is critical for autoinflammatory pathology in a mouse model of Familial Mediterranean Fever
Kanneganti, A., Malireddi, R. K. S., Saavedra, P. H. V., Vande Walle, L., Van Gorp, H., Kambara, H., Tillman, H., Vogel, P., Luo, H. R., Xavier, R. J., et al. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20172060 · Cited by 179
Jahrling, P. B., Hensley, L. E., Martinez, M. J., LeDuc, J. W., Rubins, K. H., Relman, D. A., & Huggins, J. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405954101 · Cited by 171
Human infection by avian influenza A H5N1.
Yuen, K., & Wong, S. S. Y. (2005) · PubMed · Cited by 168
Schwarzer, R., Laurien, L., & Pasparakis, M. (2020) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2020.02.004 · Cited by 160
Cauwels, A. (2007) · Kidney International · doi:10.1038/sj.ki.5002340 · Cited by 158
RIP1-driven autoinflammation targets IL-1α independently of inflammasomes and RIP3
Lukens, J. R., Vogel, P., Johnson, G. R., Kelliher, M. A., Iwakura, Y., Lamkanfi, M., & Kanneganti, T.-D. (2013) · Nature · doi:10.1038/nature12174 · Cited by 158
Self-citationBench-to-bedside review: Sepsis - from the redox point of view
Andrades, M., Morina, A., Spasić, S., & Spasojević, I. (2011) · Critical Care · doi:10.1186/cc10334 · Cited by 158
Tumor necrosis factor as a mediator of inflammation in influenza A viral pneumonia
Peper, R. L., & Campen, H. V. (1995) · Microbial Pathogenesis · doi:10.1006/mpat.1995.0056 · Cited by 155
RIPK1 Kinase-Dependent Death: A Symphony of Phosphorylation Events
Delanghe, T., Dondelinger, Y., & Bertrand, M. J. M. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.12.009 · Cited by 154
Mechanisms of action of ruxolitinib in murine models of hemophagocytic lymphohistiocytosis
Albeituni, S., Verbist, K., Tedrick, P., Sheppard, H., Picarsic, J. L., Bassett, R., & Nichols, K. E. (2019) · Blood · doi:10.1182/blood.2019000761 · Cited by 150
Lee, S. H., Kwon, J. Y., Kim, S. Y., Jung, K., & Cho, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-09767-0 · Cited by 148
Brück, N., Suttorp, M., Kabus, M., Heubner, G., Gahr, M. L., & Peßler, F. (2011) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e318205092d · Cited by 142
Unopposed IL-18 signaling leads to severe TLR9-induced macrophage activation syndrome in mice
Girard-Guyonvarc’h, C., Palomo, J., Martin, P., Rodriguez, E., Troccaz, S., Palmer, G., & Gabay, C. (2018) · Blood · doi:10.1182/blood-2017-06-789552 · Cited by 142
Resistance to Endotoxin Shock in Transgenic Mice Overexpressing Endothelial Nitric Oxide Synthase
Yamashita, T., Kawashima, S., Ohashi, Y., Ozaki, M., Ueyama, T., Ishida, T., Inoue, N., Hirata, K., Akita, H., & Yokoyama, M. (2000) · Circulation · doi:10.1161/01.cir.101.8.931 · Cited by 140
Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes
Kullenberg, T., Löfqvist, M., Leinonen, M., Goldbach‐Mansky, R. T., & Olivecrona, H. (2016) · Rheumatology · doi:10.1093/rheumatology/kew208 · Cited by 138
Binder, D., van den Broek, M. F., Kägi, D., Bluethmann, H., Fehr, J., Hengartner, H., & Zinkernagel, R. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.11.1903 · Cited by 136
NLRP3 inflammasome plays a redundant role with caspase 8 to promote IL-1β–mediated osteomyelitis
Gurung, P., Burton, A. R., & Kanneganti, T. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1601636113 · Cited by 135
Self-citationGrom, A. A., Ilowite, N. T., Pascual, V., Brunner, H. I., Martini, A., Lovell, D. J., Ruperto, N., Leon, K., Lheritier, K., & Abrams, K. B. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39407 · Cited by 130
Intestinal Inflammation and Dysregulated Immunity in Patients With Inherited Caspase-8 Deficiency
Lehle, A. S., Farin, H. F., Marquardt, B., Michels, B. E., Magg, T., Li, Y., Liu, Y., Ghalandary, M., Lammens, K., Hollizeck, S., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.09.041 · Cited by 130
Sensing of endogenous nucleic acids by ZBP1 induces keratinocyte necroptosis and skin inflammation
Devos, M., Tanghe, G., Gilbert, B., Dierick, E., Verheirstraeten, M., Nemegeer, J., de Reuver, R., Lefebvre, S., Munck, J. D., Rehwinkel, J., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20191913 · Cited by 128
The role of Interleukin 6 inhibitors in therapy of severe COVID-19
Nasonov, E. L., & MIu, S. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110698 · Cited by 128
Familial hemophagocytic lymphohistiocytosis and viral infections
Henter, J., Ehrnst, A., Andersson, J., & Elinder, G. (1993) · Acta Paediatrica · doi:10.1111/j.1651-2227.1993.tb12699.x · Cited by 127
Prencipe, G., Caiello, I., Pascarella, A., Grom, A. A., Bracaglia, C., Chatel, L., Ferlin, W. G., Marasco, E., Strippoli, R., de Min, C., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.07.021 · Cited by 125
The Mechanism of Superantigen-Mediated Toxic Shock: Not a Simple Th1 Cytokine Storm
Faulkner, L., Cooper, A., Fantino, C., Altmann, D. M., & Sriskandan, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6870 · Cited by 122
Responses to Cytokines and Interferons that Depend upon JAKs and STATs
Stark, G. R., Cheon, H., & Wang, Y. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028555 · Cited by 122
Mares, C. A., Ojeda, S. S., Morris, E. G., Li, Q., & Teale, J. M. (2008) · Infection and Immunity · doi:10.1128/iai.00215-08 · Cited by 116
Shiffman, M. L., Freilich, B. L., Vuppalanchi, R., Watt, K. D. S., Chan, J. L., Spada, A., Hagerty, D. T., & Schiff, E. R. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15030 · Cited by 115
Qiu, P., Cui, X., Sun, J., Welsh, J. A., Natanson, C., & Eichacker, P. Q. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182982add · Cited by 114
Lounder, D. T., Bin, Q., de Min, C., & Jordan, M. B. (2019) · Blood Advances · doi:10.1182/bloodadvances.2018025858 · Cited by 113
Inducible nitric oxide synthase (iNOS) gene deficiency increases the mortality of sepsis in mice
Cobb, J. P., Hotchkiss, R. S., Swanson, P. E., Chang, K. C., Qiu, Y., Laubach, V. E., Karl, I. E., & Buchman, T. G. (1999) · Surgery · doi:10.1016/s0039-6060(99)70189-3 · Cited by 112
FDA Approval: Siltuximab for the Treatment of Patients with Multicentric Castleman Disease
Deisseroth, A., Ko, C., Nie, L., Zirkelbach, J. F., Zhao, L. Y., Bullock, J. M., Mehrotra, N., Valle, P. D., Saber, H., Sheth, C. M., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1678 · Cited by 110
Meyer, L. K., Verbist, K., Albeituni, S., Scull, B., Bassett, R., Stroh, A. N., Sheppard, H., Allen, C. E., Hermiston, M. L., & Nichols, K. E. (2020) · Blood · doi:10.1182/blood.2020006075 · Cited by 104
Merola, J. F., Elewski, B. E., Tatulych, S., Lan, S.-P., Tallman, A. M., & Kaur, M. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2017.01.053 · Cited by 99
Casper, C., Chaturvedi, S., Munshi, N., Wong, R., Qi, M., Schaffer, M., Bandekar, R., Hall, B., van de Velde, H., Vermeulen, J., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0134 · Cited by 97
Kluger, N., Gil-Bistes, D., Guillot, B., & Bessis, D. (2011) · Dermatology · doi:10.1159/000326112 · Cited by 97
Kishida, S., Sanjo, H., Akira, S., Matsumoto, K., & Ninomiya‐Tsuji, J. (2005) · Genes to Cells · doi:10.1111/j.1365-2443.2005.00852.x · Cited by 94
Incidence and clinical presentation of primary hemophagocytic lymphohistiocytosis in Sweden
Meeths, M., Horne, A., Sabel, M., Bryceson, Y. T., & Henter, J. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.25308 · Cited by 93
The innate immune system and cell death in autoinflammatory and autoimmune disease
Place, D. E., & Kanneganti, T. (2020) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.10.013 · Cited by 90
Self-citationRodríguez–Lago, I., de la Piscina, P. R., Elorza, A., Merino, O., de Zárate, J. O., & Cabriada, J. L. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.04.043 · Cited by 88
Jessen, B., Kögl, T., Sepulveda, F. E., Basile, G. D. S., Aichele, P., & Ehl, S. R. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00448 · Cited by 84
Efficacy of JAK inhibitors in Crohn’s Disease
Rogler, G. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz186 · Cited by 83
Cytopathology or immunopathology? The puzzle of cytomegalovirus pneumonitis revisited
Barry, S. M., Johnson, M., & Janossy, G. (2000) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702562 · Cited by 81
Rapid Regulatory T-Cell Response Prevents Cytokine Storm in CD28 Superagonist Treated Mice
Gogishvili, T., Langenhorst, D., Lühder, F., Elias, F., Elflein, K., Dennehy, K. M., Gold, R., & Hünig, T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004643 · Cited by 79
The Inflammatory Caspases-1 and -11 Mediate the Pathogenesis of Dermatitis in Sharpin-Deficient Mice
Douglas, T., Champagne, C., Morizot, A., Lapointe, J., & Saleh, M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500542 · Cited by 77
Yasin, S., Solomon, K., Canna, S., Girard-Guyonvarc’h, C., Gabay, C., Schiffrin, E. J., Sleight, A. J., Grom, A. A., & Schulert, G. S. (2019) · Lara D. Veeken · doi:10.1093/rheumatology/kez284 · Cited by 76
Lethal synergism between influenza infection and staphylococcal enterotoxin B in mice
Zhang, W. J., Sarawar, S. R., Nguyen, P., Daly, K. R., Rehg, J. E., Doherty, P. C., Woodland, D. L., & Blackman, M. A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.11.5049 · Cited by 69
Features of sepsis caused by pulmonary infection with Francisella tularensis Type A strain
Sharma, J., Mares, C. A., Li, Q., Morris, E. G., & Teale, J. M. (2011) · Microbial Pathogenesis · doi:10.1016/j.micpath.2011.03.007 · Cited by 66
Canakinumab as treatment for COVID-19-related pneumonia: A prospective case-control study
Generali, D., Bosio, G., Malberti, F., Antonio, C., Testa, S., Romanini, L., Fioravanti, A., Morandini, A., Pianta, L., Giannotti, G., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.12.073 · Cited by 65
IFN-γ and CD25 drive distinct pathologic features during hemophagocytic lymphohistiocytosis
Humblet‐Baron, S., Franckaert, D., Dooley, J., Ailal, F., Bousfiha, A. A., Deswarte, C., Oleaga‐Quintas, C., Casanova, J., Bustamante, J. C., & Liston, A. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.10.068 · Cited by 62
Primate testing of TGN1412: right target, wrong cell
Pallardy, M. J., & Hünig, T. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00925.x · Cited by 45
Loh, N. K., Lucas, M., Fernández, S., & Prentice, D. A. (2012) · Internal Medicine Journal · doi:10.1111/imj.12002 · Cited by 42
[Influenza-associated encephalopathy--pathophysiology and disease mechanisms].
Yokota, S. (2003) · PubMed · Cited by 40
Cited by
Innate immunity: the first line of defense against SARS-CoV-2
Diamond, M. S., & Kanneganti, T.-D. (2022) · Nature Immunology · doi:10.1038/s41590-021-01091-0 · Cited by 618
Self-citationAcute Pancreatitis: Diagnosis and Treatment
Szatmary, P., Grammatikopoulos, T., Cai, W., Huang, W., Mukherjee, R., Halloran, C., Beyer, G., & Sutton, R. (2022) · Drugs · doi:10.1007/s40265-022-01766-4 · Cited by 615
Wang, Y., & Kanneganti, T.-D. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.07.038 · Cited by 545
Self-citationKarki, R., Lee, S., Mall, R., Pandian, N., Wang, Y., Sharma, B. R., Malireddi, R. S., Yang, D., Trifkovic, S., Steele, J. A., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abo6294 · Cited by 350
Self-citationProgrammed Cell Death Tunes Tumor Immunity
Liu, J., Hong, M., Li, Y., Chen, D., Wu, Y., & Hu, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.847345 · Cited by 316
Metadata
- Authors
- Karki, R., & Kanneganti, T.-D.
- Venue
- Trends in Immunology
- Publisher
- Elsevier BV
- Published
- 2021-08
- Volume
- 42
- Issue
- 8
- Pages
- 681-705
- ISSN
- 1471-4906 (ISSN-L)
- OpenAlex
- W3174877434
- Cited by
- 438
- References
- 207
- FWCI
- 5.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.